Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.12 is 36% above its 5-year average of 4.51, around the middle of its 5-year range (1.92–10.50).
As of the fiscal period ended Tuesday, June 30, 2026. 4.40% below its 12-month average of 6.40.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.12.
CURRENT RATIO
6.12
CURRENT RATIO AVG TTM
6.40
CURRENT RATIO AVG 3Y
3.97
CURRENT RATIO AVG 5Y
4.51
CURRENT RATIO AVG 10Y
5.84
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-4.40%
CURRENT VS 3Y AVG
+54.23%
CURRENT VS 5Y AVG
+35.57%
CURRENT VS 10Y AVG
+4.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+63.21%
vs the sector median at left
Spero Therapeutics, Inc.
Market Cap
$69.19M
Current Ratio
6.12
TTM Avg
6.40
3Y Avg
3.97
5Y Avg
4.51
Market Cap
$67.66M
Current Ratio
1.03
TTM Avg
0.95
3Y Avg
0.86
5Y Avg
0.95
Market Cap
$68.72M
Current Ratio
0.76
TTM Avg
0.89
3Y Avg
1.63
5Y Avg
3.63
Market Cap
$72.49M
Current Ratio
1.45
TTM Avg
2.17
3Y Avg
5.05
5Y Avg
3.92
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | $69.19M | 6.12 | 6.40 | 3.97 | 4.51 |
| Champions Oncology, Inc. (CSBR)vs › | $67.66M | 1.03 | 0.95 | 0.86 | 0.95 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 3.96 | 1.88 | 1.73 | 2.58 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.72M | 0.76 | 0.89 | 1.63 | 3.63 |
| iBio, Inc. (IBIO)vs › | $66.56M | 7.85 | 4.72 | 3.68 | 5.33 |
| Cingulate Inc. (CING)vs › | $66.69M | 3.50 | 1.85 | 1.22 | 3.58 |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.49M | 1.45 | 2.17 | 5.05 | 3.92 |
| MindWalk Holdings Corp. (HYFT)vs › | $71.42M | 1.84 | 2.44 | 2.28 | 3.54 |
| XBiotech Inc. (XBIT)vs › | $66.16M | 33.15 | 13.79 | 28.68 | 44.67 |
| Gain Therapeutics, Inc. (GANX)vs › | $72.01M | 4.36 | 4.80 | 4.58 | 6.22 |
Current Ratio
6.12
Quick Ratio
6.12
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.12 |
| 2026-03-31 | 10.50 |
| 2025-12-31 | 7.59 |
| 2025-09-30 | 3.83 |
| 2025-06-30 | 3.97 |
| 2025-03-31 | 2.56 |
| 2024-12-31 | 2.19 |
| 2024-09-30 | 2.68 |
| 2024-06-30 | 2.68 |
| 2024-03-31 | 3.35 |
| 2023-12-31 | 3.53 |
| 2023-09-30 | 4.01 |
| 2023-06-30 | 5.10 |
| 2023-03-31 | 4.42 |
| 2022-12-31 | 5.04 |
| 2022-09-30 | 3.26 |
| 2022-06-30 | 3.65 |
| 2022-03-31 | 1.92 |
| 2021-12-31 | 8.46 |
| 2021-09-30 | 7.64 |
| 2021-06-30 | 8.29 |
| 2021-03-31 | 7.29 |
| 2020-12-31 | 9.70 |
| 2020-09-30 | 8.12 |
| 2020-06-30 | 4.49 |
| 2020-03-31 | 4.31 |
| 2019-12-31 | 3.58 |
| 2019-09-30 | 6.90 |
| 2019-06-30 | 13.66 |
| 2019-03-31 | 17.48 |
| 2018-12-31 | 9.37 |
| 2018-09-30 | 13.01 |
| 2018-06-30 | 10.68 |
| 2018-03-31 | 13.67 |
| 2017-12-31 | 10.70 |
| 2017-09-30 | 3.92 |
| 2017-06-30 | 5.85 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 1.72 |
| 2016-09-30 | 0.00 |
